PhotoMedex, Inc. (NASDAQ: PHMD) (TASE: PHMD) today announced that
it expects revenues for the fourth quarter of 2013 to be more than $60
million without any contribution from Japan, compared with prior
guidance issued on November 6, 2013 for revenues for the fourth quarter
of 2013 to be more than $55 million without any expected contribution
from Japan. The Company attributes the quarterly revenue outperformance
to holiday advertising in the Consumer business segment that yielded
global direct response sales above prior forecasts, as well as to
better-than-expected sales to retail and home shopping channel customers.
Commenting on the raised guidance, Dr. Dolev Rafaeli, chief executive
officer of PhotoMedex, said, “Consumer demand for no!no! is strong and
our advertising spend for the new no!no! Pro during the Christmas
holiday season generated a very high media efficiency ratio. In other
positive developments, we are experiencing strong patient response to
our XTRAC™ advertising campaign in major markets. We are pleased that
for the fourth consecutive quarter XTRAC treatment revenues grew by more
than 50% over the prior-year comparison, and for the 12 months ended
December 31, 2013 grew by more than 80% over the prior year.”
PhotoMedex expects to release financial results for the fourth quarter
of 2013 and hold an investment-community conference call in mid-March
2014.
About PhotoMedex
PhotoMedex is a global skin health company providing integrated disease
management and aesthetic solutions to dermatologists, professional
aestheticians and consumers. The company provides proprietary products
and services that address skin diseases and conditions including
psoriasis, vitiligo, acne, actinic keratosis (a precursor to certain
types of skin cancer) and photo damage. Its experience in the physician
market provides the platform to expand its skin health solutions to spa
markets, as well as traditional retail, online and infomercial outlets
for home-use products. As a result of its December 2011 merger with
Radiancy Inc., PhotoMedex has added a range of home-use devices under
the no!no!™ brand, for various indications including hair removal, acne
treatment and skin rejuvenation. The company also offers a professional
product line for acne clearance, skin tightening, psoriasis care and
hair removal sold to physician clinics and spas.
SAFE HARBOR STATEMENT
Some portions of this press release, particularly those describing
PhotoMedex' strategies, operating expense reductions and business plans
will contain "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995 that are subject to
risks, uncertainties and other factors. All statements other than
statements of historical fact are statements that could be deemed
forward-looking statements, including any statements of the plans,
strategies and objectives of management for future operations; any
statements regarding product development, product extensions, product
integration or product marketing; any statements regarding continued
compliance with government regulations, changing legislation or
regulatory environments; any statements of expectation or belief and any
statements of assumptions underlying any of the foregoing. These risks,
uncertainties and other factors, and the general risks associated with
the businesses of the Company described in the reports and other
documents filed with the SEC, could cause actual results to differ
materially from those referred to, implied or expressed in the
forward-looking statements. The Company cautions readers not to rely on
these forward-looking statements. All forward-looking statements are
based on information currently available to the Company and are
qualified in their entirety by this cautionary statement. The Company
anticipates that subsequent events and developments will cause its views
to change. The information contained in this press release speaks as of
the date hereof and the Company has or undertakes no obligation to
update or revise these forward-looking statements, whether as a result
of new information, future events or otherwise.
Copyright Business Wire 2014